Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar
Nahla I
NI
Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Gaefar
Hattem A
HA
D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000235:genetics; D002272:Carcinoembryonic Antigen / Q000097:blood*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007118:Immunoassay; D060785:Mammaglobin A; D008875:Middle Aged; D018396:Mucin-1 / Q000097:blood*; D009185:Myelin Proteins / Q000235:genetics; D009363:Neoplasm Proteins / Q000235:genetics; D011510:Proteolipids / Q000235:genetics; D012333:RNA, Messenger / Q000097:blood* / Q000235:genetics; D012372:ROC Curve; D020133:Reverse Transcriptase Polymerase Chain Reaction; D060765:Secretoglobins; D014598:Uteroglobin / Q000235:genetics
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D060785:Mammaglobin A; D018396:Mucin-1; D009185:Myelin Proteins; D009363:Neoplasm Proteins; D011510:Proteolipids; D012333:RNA, Messenger; C556448:SCGB2A2 protein, human; D060765:Secretoglobins; D014598:Uteroglobin